Risk factors for adenomyosis in patients with symptomatic uterine leiomyomas.

Romanek K, Katarzyna Romanek, Bartuzi A, Aleksandra Bartuzi, Michał Bogusiewicz, Rechberger T, Tomasz Rechberger
Ginekologia polska · 2010 · vol. 81(9) , pp. 678–80 · PMID:20968175 · W2415269561
article OA: green CC0 ⤵ 7 in-corpus citations
🔓 Open OA copy Full text JSON View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-07, 2026-07-18 ⓘ

This study found that multiparity is a risk factor for adenomyosis in women with symptomatic uterine leiomyomas, based on a retrospective review of hysterectomy patients.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: The aim of the study was to evaluate the potential risk factors for adenomyosis in patients with symptomatic uterine leiomyomas. MATERIAL AND METHODS: The medical charts and histopathology reports of 1499 women who underwent hysterectomy between 2003-2007 were retrospectively reviewed. The study group was composed of 135 patients with coexisting uterine leiomyoma and adenomyosis. The control group comprised 176 patients with uterine leiomyoma without adenomyosis. RESULTS: Among 233 patients with adenomyosis 135 (57.9%) had associated uterine fibroids. Women who delivered twice or more were at increased risk for adenomyosis in relation to nulliparuos women: RR (95% CI) 2.44 (1.04-5.72), p = 0.040. No relationship was found between adenomyosis and cesarean section rate, abortions, menorrhagia or dysmenorrhea. CONCLUSION: Results of our study indicate that multiparity is a risk factor for adenomyosis in women with symptomatic leiomyomas.
Full text 1,161 characters · extracted from oa-html · 2 sections · click to expand

Abstract

Summary Objective: The aim of the study was to evaluate the potential risk factors for adenomyosis in patients with symptomatic uterine leiomyomas. Material and methods: The medical charts and histopathology reports of 1499 women who underwent hysterectomy between 2003-2007 were retrospectively reviewed. The study group was composed of 135 patients with coexisting uterine leiomyoma and adenomyosis. The control group comprised 176 patients with uterine leiomyoma without adenomyosis. Results: Among 233 patients with adenomyosis 135 (57.9%) had associated uterine fibroids. Women who delivered twice or more were at increased risk for adenomyosis in relation to nulliparuos women: RR (95% CI) 2.44 (1.04-5.72), p=0.040. No relationship was found between adenomyosis and cesarean section rate, abortions, menorrhagia or dysmenorrhea. Conclusion: Results of our study indicate that multiparity is a risk factor for adenomyosis in women with symptomatic leiomyomas.

Keywords

adenomyosisuterine leiomyomahysterectomyparity

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisadenomyosisdysmenorrhea

MeSH descriptors

Endometriosis Leiomyoma Uterine Neoplasms Women's Health Aged Comorbidity Endometriosis Endometriosis Endometriosis Female Humans Leiomyoma Leiomyoma Leiomyoma Middle Aged Poland Poland Prevalence Retrospective Studies Risk Factors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (7)

Source provenance

europepmc
last seen: 2026-08-03T06:10:56.557307+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:17:00.782903+00:00
License: CC0 · commercial use OK